Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Bio-Implants Market Forecast: What Value Will The Market Reach By 2030?
The bio-implants market size has shown substantial growth in recent years. Its expansion is anticipated to be from $136.96 billion in 2025 to $152.24 billion in 2026, achieving a compound annual growth rate (CAGR) of 11.2%. Factors such as the rising prevalence of chronic orthopedic and cardiovascular disorders, increasing surgical intervention rates, advancements in biomaterial science, a growing aging population, and wider acceptance of implant-based therapies contributed to its historic growth.
The bio-implants market size is anticipated to expand significantly over the coming years. It will grow to $228.53 billion in 2030 at a compound annual growth rate (CAGR) of 10.7%. The expansion during this forecast period is largely driven by increasing investments in regenerative medicine, the rising adoption of 3D-printed implants, a growing focus on personalized healthcare solutions, the expansion of outpatient surgical procedures, and an increasing demand for next-generation bio-implants. Prominent trends for the forecast period include the increasing adoption of biocompatible implant materials, a rising demand for customized and patient-specific implants, the growing use of minimally invasive implant procedures, the expansion of regenerative and tissue-engineered implants, and an enhanced focus on long-term implant durability.
Get A Free Sample Report With In-Depth Market Insights:
Bio-Implants Market Opportunity Drivers: What’s Unlocking New Revenue Potential?
The growing occurrence of chronic conditions is projected to propel the bio-implant market ahead. Such conditions, including cardiovascular diseases and arthritis, are defined as medical ailments lasting a year or more, necessitating ongoing medical attention, and limiting daily routines. Bio-implants play a role in the management and monitoring of chronic conditions, helping to lower the death rate resulting from these illnesses. As an illustration, data from June 2024, provided by the National Health Service, a UK government department, revealed that 3,615,330 individuals registered with a general practitioner (GP) received a diagnosis of non-diabetic hyperglycemia or pre-diabetes (a state characterized by elevated blood sugar levels, insufficient for a diabetes diagnosis) in 2023. This represented an 18% rise from the 3,065,825 cases recorded in 2022. Consequently, the rising incidence of chronic conditions is stimulating the expansion of the bio-implant market.
Bio-Implants Market Segment Landscape And Growth Outlook
The bio-implants market covered in this report is segmented –
1) By Type: Cardiovascular Implants, Dental Implants, Spinal Bio-Implants, Orthopedic Implants, Ophthalmic Implants, Other Types
2) By Material: Metallic, Ceramic, Polymer, Biological
3) By Origin: Allograft, Autograft, Xenograft, Synthetic
4) By End-User: Ambulatory Surgical Centers, Clinics, Hospital, Other End-Users
Subsegments:
1) By Cardiovascular Implants: Stents, Heart Valves, Pacemakers
2) By Dental Implants: Endosteal Implants, Subperiosteal Implants, Zygomatic Implants
3) By Spinal Bio-Implants: Spinal Fusion Devices, Intervertebral Discs, Spinal Rods And Plates
4) By Orthopedic Implants: Joint Replacement Implants, Fracture Fixation Devices, Bone Plates And Screws
5) By Ophthalmic Implants: Intraocular Lenses (IOLs), Retinal Implants, Corneal Implants
6) By Other Types: Cochlear Implants, Tissue Engineering Implants, Biomaterial Scaffolds
Bio-Implants Market Innovation Trends Shaping Future Development
Major companies in the bio-implants market are introducing novel implants, such as the REGENETEN Bioinductive Implants, to advance patient care standards. The REGENETEN Bioinductive Implant is a solution based on collagen that supports the body’s natural healing response by facilitating the growth of new tendon-like tissue. For instance, in July 2023, Smith+Nephew, a UK-based medical technology company, launched its REGENETEN Bioinductive Implant in India, having completed over 100,000 global procedures since its initial introduction. This collagen-based implant aids the body’s natural healing process, promoting the development of new tendon-like tissue to augment existing tendons. Delivered arthroscopically, this implant, initially the size of a postage stamp, became invisible in six months, replaced by new tendon-like tissue. This implant has demonstrated favorable results in rotator cuff disease, with a recent trial showing an 86% relative reduction in re-tear rates at 12 months compared to conventional surgery alone.
Bio-Implants Market Top Companies Driving Competitive Growth
Major companies operating in the bio-implants market are Medtronic PLC, Stryker Corporation, Zimmer Biomet Holdings Inc., Dentsply Sirona Inc., Johnson & Johnson, Arthrex Inc., Boston Scientific Corporation, Smith & Nephew PLC, B. Braun Melsungen AG, Straumann Holding AG, Organogenesis Holdings Inc., Exactech Inc., Edwards Lifesciences Corporation, Biotronik SE & Co. KG, aap Implantate AG, Abbott Laboratories, Cook Medical LLC, Globus Medical Inc., Integra LifeSciences Holdings Corporation, LivaNova PLC, MicroPort Scientific Corporation, NuVasive Inc., Orthofix Medical Inc., RTI Surgical Holdings Inc., Terumo Corporation
View The Full Bio-Implants Market Report:
Bio-Implants Market Global Footprint: Which Region Leads The Market?
North America was the largest region in the bio-implants market share in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bio-implants market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
